A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells

Pathology International

Volumn 49, Issue 10, 1999, Pages 898-902

  Nakamura, Yoichi ^a,c   Yutani, Chikao ^a   Nakazato, Masamitsu ^b   Date, Yukari ^b   Baba, Takeshi ^a   Goto, Yoichi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Familial amyloid polyneuropathy; Heart failure; Prealbumin

Indexed keywords

PREALBUMIN;

ADULT; AMYLOIDOSIS; ARTICLE; AUTOPSY; CARDIOMYOPATHY; CASE REPORT; DNA SEQUENCE; FEMALE; GENETIC DISORDER; GIANT CELL; HISTOPATHOLOGY; HUMAN; MACROPHAGE; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRIORITY JOURNAL;

AGED; AMYLOID NEUROPATHIES; AMYLOIDOSIS; BASE SEQUENCE; CARDIOMYOPATHIES; FEMALE; GIANT CELLS; HEART VENTRICLES; HUMANS; METHIONINE; POINT MUTATION; PREALBUMIN; RECTUM;

EID: 0032703097     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00962.x     Document Type: Article

References (16)

1. Harada T, Kito S, Shimoyama M et al. Genetic and clinical studies of Japanese patients with familial amyloid polyneuropathy. Eur Neurol. 1989; 29: 48-52.
2. Benson MD, Uemichi T. Transthyretin amyloidosis: Amyloid. Int. J. Exp. Clin. Invest. 1996; 3: 44-56.
3. Nichols WC, Liepnieks JJ, Snyder EL, Benson MD. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J. Lab. Clin. Med. 1991; 117: 175-180.
4. Saraiva MJM, Almeida MR, Sherman W et al. A new transthyretin mutation associated with amyloid cardiomyopathy. Am. J. Hum. Genet. 1992; 50: 1027-1030.
5. Nordlie M, Sletten K, Husby G, Ranløv PJ. A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand. J. Immunol. 1988; 27: 119-122.
6. Almeida MR, Hesse A, Steinmetz A et al. Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res. Cardiol. 1991; 86: 567-571.
7. Jacobson DR, Pan T, Kyle RA, Buxbaum JN. Transthyretin ILE 20, a new variant associated with late-onset cardiac amyloidosis. Hum. Mutat. 1997; 9: 83-85.
8. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin. Proc. 1984; 59: 547-555.
9. Date Y, Nakazato M, Kangawa K, Shirieda K, Fujimoto T, Matsukura S. Detection of three transthyretin gene mutations in familial amyloidotic polyneuropathy by analysis of DNA extracted from formalin-fixed and paraffin-embedded tissues. J. Neurol. Sci. 1997; 150: 143-148.
10. Hamilton JA, Steinrauf LK, Braden BC et al. The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30→Met variant to 1.7-Ä resolution. J. Biol. Chem. 1993; 268: 2416-2424.
11. Walley VM, Kisilevsky R, Young D. Amyloid and the cardiovascular system: A review of pathogenesis and pathology with clinical correlations. Cardiovasc. Pathol. 1995; 4: 79-102.
12. Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U. Systemic distribution of β2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis: Report of seven cases and review of the literature. Arch. Pathol. Lab. Med. 1994; 118: 718-721.
13. Jacobson DR, Buxbaum JN. A double-variant transthyretin allele (SER 6, ILE 33) in the Israeli patient 'SKO' with familial amyloidotic polyneuropathy. Hum. Mutat. 1994; 3: 254-260.
14. McCutchen SL, Lai Z, Miroy GJ, Kelly JW, Colón W. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 1995; 34: 13527-13536.
15. Nakazato M, Shomi K, Miyazato M, Matsukura S. Type I familial amyloidotic polyneuropathy in Japan. Int. Med. 1992; 31: 1335-1338.
16. Westermark P, Sletten K, Johansson B, Corvwell GG III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA 1990; 87: 2843-2845.